U.S. Markets closed
  • S&P 500

    4,662.85
    +3.82 (+0.08%)
     
  • Dow 30

    35,911.81
    -201.79 (-0.56%)
     
  • Nasdaq

    14,893.75
    +86.95 (+0.59%)
     
  • Russell 2000

    2,162.46
    +3.02 (+0.14%)
     
  • Crude Oil

    84.30
    +0.48 (+0.57%)
     
  • Gold

    1,818.90
    +2.40 (+0.13%)
     
  • Silver

    23.03
    +0.12 (+0.51%)
     
  • EUR/USD

    1.1416
    0.0000 (-0.0000%)
     
  • 10-Yr Bond

    1.7720
    +0.0610 (+3.57%)
     
  • Vix

    19.19
    -1.12 (-5.51%)
     
  • GBP/USD

    1.3641
    -0.0038 (-0.2810%)
     
  • USD/JPY

    114.5850
    +0.3850 (+0.3371%)
     
  • BTC-USD

    42,286.09
    -712.16 (-1.66%)
     
  • CMC Crypto 200

    1,016.19
    -9.54 (-0.93%)
     
  • FTSE 100

    7,611.23
    +68.28 (+0.91%)
     
  • Nikkei 225

    28,333.52
    +209.24 (+0.74%)
     

GTCR portfolio company Resonetics valued at $2.25 billion in minority stake sale to Carlyle

·1 min read
GTCR portfolio company Resonetics valued at $2.25 billion in minority stake sale to Carlyle
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Private equity firm GTCR said Friday it sold a minority equity stake in portfolio company, Resonetics to funds affiliated with Carlyle in a deal that values the Nashua, N.H., medical device micro-manufacturer at about $2.25 billion. The firms did not disclose the dollar amount of the minority investment. Carlyle will join GTCR as a "meaningful shareholder" in Resonetics, the firm said. GTCR made its initial investment in Resonetics in 2018 in partnership with medical technology industry executiv